AKT1 and cancer: These alterations, especially common in endometrioid and clear cell ovarian cancers, lead to excessive AKT activation and correlate with poorer survival, chemotherapy resistance, and enhanced cancer stem cell traits that drive recurrence and aggressiveness [14].